Meridian Bioscience Inc (NASDAQ:VIVO)

14.50
Delayed Data
As of Feb 16
 -0.05 / -0.34%
Today’s Change
12.45
Today|||52-Week Range
16.45
+3.57%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a +10.34% increase from the last price of 14.50.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.21
Sales
$54.7M
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.89%
 
 
 
 
 
 
Growthannually 5.33%
 
 
 
 
 
 

Sales

Growthquarterly 4.63%
 
 
 
 
 
 
Growthannually 4.73%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.